AI assistant
Sending…
Mawson Infrastructure Group Inc. — Director's Dealing 2017
Nov 27, 2017
35202_dirs_2017-11-27_c1ca05e0-fde6-4aec-891e-b6b9fde7128f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2017-11-16
Reporting Person: Fisher Shimshon (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Convertible Notes | $0.05 | 2017-12-31 | Common Stock, par value $0.001 per share (6075385) | Direct | |
| Future Investment Rights | $0.06 | 2019-06-30 | Common Stock, par value $0.001 per share (7401033) | Direct |
More from Mawson Infrastructure Group Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 18
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 6
Proxy Solicitation & Information Statement
2026
Feb 4
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30